KITS πŸ“ˆ Kits Eyecare - Overview

Exchange: TO β€’ Country: Canada β€’ Currency: CAD β€’ Type: Common Stock β€’ ISIN: CA49804N1042

KITS: Eyeglasses, Contact Lenses, Frames, Progressive Lenses

Kits Eyecare Ltd. operates a digital eyecare platform in the United States and Canada. It manufactures progressive and contact lenses, eyeglasses, and frames under the KITS brand, as well as distributes eyewear products of various brands. The company operates through a network of optical e-commerce websites, including KITS.com, KITS.ca, OptiContacts.com, and ContactsExpress.ca. Kits Eyecare Ltd. was founded in 2002 and is headquartered in Vancouver, Canada. Web URL: https://www.kits.com

Additional Sources for KITS Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

KITS Stock Overview

Market Cap in USD 185m
Sector Consumer Cyclical
Industry Specialty Retail
GiC Sub-Industry Other Specialty Retail
IPO / Inception

KITS Stock Ratings

Growth 5y 16.0%
Fundamental 17.8%
Dividend -
Rel. Strength Industry 39.5
Analysts -
Fair Price Momentum 7.40 CAD
Fair Price DCF 4.18 CAD

KITS Dividends

No Dividends Paid

KITS Growth Ratios

Growth Correlation 3m -93.3%
Growth Correlation 12m 75.6%
Growth Correlation 5y 40.1%
CAGR 5y -2.22%
CAGR/Mean DD 5y -0.05
Sharpe Ratio 12m 0.79
Alpha 25.16
Beta 0.24
Volatility 39.20%
Current Volume 11.9k
Average Volume 20d 17.2k
What is the price of KITS stocks?
As of January 03, 2025, the stock is trading at CAD 8.30 with a total of 11,872 shares traded.
Over the past week, the price has changed by +0.00%, over one month by -7.26%, over three months by -17.90% and over the past year by +36.29%.
Is Kits Eyecare a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Kits Eyecare is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 17.80 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of KITS as of January 2025 is 7.40. This means that KITS is currently overvalued and has a potential downside of -10.84%.
Is KITS a buy, sell or hold?
Kits Eyecare has no consensus analysts rating.
What are the forecast for KITS stock price target?
According to ValueRays Forecast Model, KITS Kits Eyecare will be worth about 8 in January 2026. The stock is currently trading at 8.30. This means that the stock has a potential downside of -3.37%.
Issuer Forecast Upside
Wallstreet Target Price 15.5 86.7%
Analysts Target Price - -
ValueRay Target Price 8 -3.4%